ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $909 | -99.8% | 145,953 | +74.7% | 0.00% | 0.0% |
| Q3 2022 | $559,000 | +171.4% | 83,568 | +158.0% | 0.00% | – |
| Q2 2022 | $206,000 | -21.1% | 32,392 | -42.6% | 0.00% | – |
| Q1 2022 | $261,000 | +44.2% | 56,427 | +55.5% | 0.00% | – |
| Q4 2021 | $181,000 | -91.1% | 36,291 | -78.6% | 0.00% | -100.0% |
| Q3 2021 | $2,041,000 | +257.4% | 169,400 | +527.4% | 0.00% | +100.0% |
| Q2 2021 | $571,000 | -34.7% | 27,000 | +123.0% | 0.00% | 0.0% |
| Q1 2018 | $875,000 | +641.5% | 12,106 | +734.9% | 0.00% | – |
| Q2 2015 | $118,000 | -95.1% | 1,450 | -94.5% | 0.00% | -100.0% |
| Q1 2015 | $2,430,000 | +30275.0% | 26,245 | +13022.5% | 0.01% | – |
| Q4 2014 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |